$90.74+30.66% · 3M
Moving avg
1W+1.28%
1M+5.77%
3M+30.66%
6M+11.08%
YTD+18.12%
1Y+34.43%
3Y+17.69%
5Y+20.03%
52-week range
$61.95100% of range$89.34
Company health
Value4/6
Growth1/6
Profitability3/6
Health2/6
Dividend0/6
Bull vs bear
Strengths
- Analyst consensus is "Buy"
- High return on equity (1186%)
Risks
No obvious red flags from the metrics.
Key statistics
Valuation
Market cap
$10.34B
Enterprise value
$13.24B
P/E ratio (TTM)
25.31x
P/S ratio (TTM)
0.72x
EV/EBITDA
13.21x
Per share & returns
EPS (TTM)
$3.44
Dividend yield
0.00%
Beta (1Y)
0.81
30-day change
+5.77%
Trading
Volume (24h)
999.68K
Previous close
$89.18
Shares outstanding
113.92M
About Henry Schein, Inc.
Sector
Healthcare
Industry
Medical - Distribution
Exchange
NASDAQ
Symbol
HSIC
Henry Schein, Inc. is a large-cap healthcare company in the Medical - Distribution industry. Its shares are listed on NASDAQ (United States) and trade under the ticker HSIC.
Frequently asked questions
What is Henry Schein, Inc.'s market cap?
Henry Schein, Inc. (HSIC) has a market capitalization of $10.34B.
What is Henry Schein, Inc.'s P/E ratio?
Henry Schein, Inc. trades at a price-to-earnings (P/E) ratio of 25.31.
What exchange does HSIC trade on?
HSIC trades on NASDAQ.
Appears in
Eli Lilly and CompanyLLY
$1,220.51+0.45%
$1.15T cap
Johnson & JohnsonJNJ
$260.86+0.41%
$628.65B cap
AbbVie Inc.ABBV
$248.66-0.57%
$439.33B cap
UnitedHealth Group IncorporatedUNH
$405.59+0.85%
$368.33B cap
Roche Holding AGSWX: ROP
CHF 364.10-0.38%
$356.56B cap
Merck & Co., Inc.MRK
$132.93+1.92%
$328.31B cap
Novartis AGSWX: NOVN
CHF 123.68-0.42%
$289.21B cap
AstraZeneca PLCLON: AZN
£116.24-0.67%
$243.04B cap